Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/23/2025

Management of Infants Born with Hepatitis B Exposure

Immediate Management at Birth (Within 12 Hours)

  • The Centers for Disease Control and Prevention recommends that all infants born to HBsAg-positive mothers must receive both hepatitis B vaccine and HBIG within 12 hours of birth at different injection sites to prevent chronic infection and its life-threatening complications of cirrhosis and hepatocellular carcinoma 1, 2
  • For infants born to HBsAg-positive mothers, administer dual prophylaxis immediately, including single-antigen hepatitis B vaccine at one injection site and HBIG (0.5 mL for newborns) at a separate injection site 1, 2
  • For infants ≥2,000 grams born to HBsAg-positive mothers, the birth dose counts as the first dose of the vaccine series 1, 2
  • For infants <2,000 grams born to HBsAg-positive mothers, the birth dose does NOT count toward the series due to reduced immunogenicity; these infants require 4 total doses (birth dose plus 3 additional doses starting at age 1 month) 1, 2

Management of Infants Born to Mothers with Unknown HBsAg Status

  • If maternal status unknown but evidence suggests HBV infection, manage as if mother is HBsAg-positive: give both vaccine and HBIG within 12 hours 3, 4
  • If maternal status completely unknown, infants ≥2,000 grams should receive hepatitis B vaccine (without HBIG) within 12 hours while expediting maternal testing 3, 4
  • If maternal status completely unknown, infants <2,000 grams should receive both vaccine AND HBIG within 12 hours if maternal status cannot be determined within 12 hours of birth 3, 4

Vaccine Series Completion

  • Complete 3-dose series (or 4-dose for infants <2,000 grams) for infants born to HBsAg-positive mothers 1, 2
  • Final dose must not be administered before age 24 weeks (164 days) 1, 3, 4

Post-Vaccination Serologic Testing

  • Test at age 9-12 months (generally at next well-child visit after completing vaccine series) for both HBsAg and anti-HBs 1, 3, 4
  • Use a method detecting anti-HBs ≥10 mIU/mL 3, 4
  • Do NOT test before 9 months to avoid detecting passive anti-HBs from birth HBIG and to maximize detection of late infection 1, 3, 4

Interpretation and Management of Results

  • If HBsAg-negative with anti-HBs ≥10 mIU/mL, infant is protected; no further management needed 3, 4, 5
  • If HBsAg-negative with anti-HBs <10 mIU/mL, revaccinate with a single dose of hepatitis B vaccine and retest 1-2 months later 3, 4, 5
  • If HBsAg-positive, infant has chronic HBV infection despite prophylaxis; refer immediately for hepatology follow-up and chronic disease management 3, 4, 5

Special Considerations

  • Infants who receive postexposure prophylaxis may be breastfed immediately after birth 3, 4, 5
  • Transferring and receiving facilities must communicate regarding vaccination and HBIG status to ensure timely prophylaxis 3, 4
  • Never assume maternal HBsAg status is accurate without verification, as documentation errors or acute maternal infection between testing and delivery can occur 6